Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Mazandaran University of Medical Sciences. 2007; 17 (60): 6-13
em Persa | IMEMR | ID: emr-83464

RESUMO

Binding a monoclonal antibody to tumor associated antigens is an effective method for cancer therapy because these agents can specifically target malignant cells. In fact, monoclonal antibodies are effective agents for diagnosis, grading and treatment of different kinds of cancers. In this research, a new monoclonal antibody against colon cancer cells was prepared and radiolabeling with technetium-99m evaluated. This research was done in three parts: preparation of hybridoma cell against colon cancer cell line [HT29], production of monoclonal antibody, determination of its characterizations and radiolabeling with technetium-99m. mAb-D2 is an IgG1 with affinity constant of 7.2x10[9] M[-1] which can recognize CEA in tumor cells. Radiolabeling showed that [99m]Tc-HYNIC-mAb-D2 complex is stable, immunoradioactive, and has a desirable biodistribution. In this study, we gained a new radiopharmaceutical that may be a good candidate for radioimmunoscintigraphy


Assuntos
Neoplasias do Colo/diagnóstico por imagem , Radioimunodetecção , Compostos Radiofarmacêuticos , Anticorpos Monoclonais , Medronato de Tecnécio Tc 99m
2.
Iranian Journal of Nuclear Medicine. 2006; 14 (26): 23-27
em Persa | IMEMR | ID: emr-77062

RESUMO

Binding a monoclonal antibody to tumor associated antigens is an effective method for cancer therapy because these agents can specifically target malignant cells, in fact monoclonal antibodies are effective agents for diagnosis, grading and treatment of different kinds of cancers. In this research, a new monoclonal antibody against colon cancer cells was prepared and antigen concentration in different cells determined by a radioimmunoassay method using iodine [I-125] labeled protein G. 125I-labeled protein G percent binding to white blood cell, HT29, LS180 and MCF7 cell lines were 7.1%, 91.2%, 75.8% and 40.2%, respectively. Regarding importance of monoclonal antibody applications, it is necessary to find an efficient method for their evaluation in cancer therapy. In this method, a radioactive agent with no count restriction was used. Also by this method, amount of the antigen can be easily quantified


Assuntos
Radioimunoensaio , Antígenos , Proteínas do Tecido Nervoso , Neoplasias do Colo , Radioisótopos do Iodo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA